A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

Update Il y a 4 ans
Reference: NCT00694941

Woman and Man

Extract

The objective of this study is to investigate the long term safety of ALS patients taking ONO-2506PO.


Inclusion criteria

  • Amyotrophic Lateral Sclerosis (ALS)


Links